Schedule your COVID-19 vaccine wherever possible. Please do not call your doctor as they cannot schedule an appointment for you. Learn more.

An Option for Stroke Protection for AFib Patients Undergoing Ablation

Trial ID:
IRB-19-7419
Douglas Gibson, M.D.
The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral anticoagulation following percutaneous catheter ablation for high risk patients with non-valvular atrial fibrillation

Inclusion Criteria

  • Be 18 years of age or older
  • Have undergone a prior catheter ablation procedure for non-valvular atrial fibrillation within 90 days of consent
  • Be willing and able to return for required follow-up visits and examinations

Exclusion Criteria

  • Be enrolled in another investigational study
  • Have had a stroke or transient ischemic attack (TIA) within the past 60 days of consent
  • Have an active infection
  • Have had surgical closure of the left atrial appendage

Additional Info

  • All treatments and physician visits during the study will take place at Anderson Medical Pavilion.
  • For more information search NCT# 03795298 on the Clinical Trials website at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Leadership
  • CRSLeadership@scrippshealth.org